Associate Director, Oncology Finance FP&A

Associate Director, Oncology Finance FP&A

• Full-time
• Salary Min: 137500
• Salary Max: 261000
• Workday Global Grade: 20
• Travel:
  No
• Compensation: USD 137,500 - USD 261,000 - yearly

Abb Vie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about Abb Vie, please visit us at  .

Follow @abbvie on X, Facebook, Instagram, You Tube, Linked In and Tik Tok.

The primary responsibility of this position is to provide financial leadership and business support for the Franchise V commercial team (Venclexta and PVEK brands) in terms of budget and Alliance Management. Specifically, this position is responsible for SG&A forecasting, monitoring and reporting, for the Venclexta Alliance Management and Alliance Accounting and reporting activities, as well as for the PVEK revenue forecasting and accounting and sales accounting.

In addition, this position is also responsible for ensuring the accuracy of the financial statements and the associated internal controls.

This position will have 1 direct report and will be responsible for their performance and development.

The Associate Director interacts with all levels of Finance team and Commercial team and business partners to consolidate Venclexta and PVEK P&L, as well as the Venclexta alliance revenues, from an actual and forecasting perspective, contributing to the development of the necessary business analytics to support the decision making process, as well as to support all the Abb Vie planning and reporting processes.

• Lead the monthly, quarterly, and annual close / reporting processes for SG&A and revenues ensuring accurate and timely reporting of results in accordance with GAAP and internal reporting requirements
• Develop effective SG&A and alliance revenue reporting, performance monitoring, and support development of contingency plans as necessary to deliver results with clear and concise commentary
• Ensure SG&A investments optimize marketing mix (MMx) and PVEK launch investments are sufficiently funded, all while understanding the strategic trade-offs involved
• Understand the Risk and Opportunities throughout the year while continually monitoring and adapting strategic tactics based on ongoing changes
• Oversee the preparation of all monthly collaboration transaction calculations, as part of the profit and cost sharing process for Venclexta
• Manage financial obligations shifts between Genentech & Abb Vie and collaboration and ex-collaboration investments
• Lead the efforts for the Genentech collaboration, ensuring appropriate collaboration-required reporting is completed

• Proactively lead the brand planning processes for SG&A and Alliance [Plan, LBE and LRP] ensuring accurate and timely integration of investment resourcing in the overall brand approach and ensuring senior management input to meet deadlines and deliverables
• Ensure an efficient management of the investments as per the annual budget defined by brand, and contribute with ideas and suggestions for funds re-allocation, based on business needs
• Accountable for generating, presenting, and maintaining SG&A and Alliance revenues forecasts with a high degree of precision and insight
• Ensure financial planning deliverables are accurate, clear, and concise for Executive level review and approval
• Coordinate with Genentech’s finance team to gain clear understanding of their actuals and shared SG&A spending for Venclexta to ensure appropriate inclusion in the Abb Vie planning cycles
• Ad-hoc analysis and scenario planning as required by the business

• Business partner with all relevant Venclexta and PVEK business functions to develop and build strong relationships, ensuring full involvement in their financials to drive growth and profitability.

• Responsible for…